R&D Changing Faces: Pharma and biotech hires – February 2025 February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number of changes at the big pharmas, which may have slipped under you
Sales & Marketing Changing Faces: Pharma and biotech January 2025 Welcome to the first edition of Changing Faces for 2025.
News Lawrence Tallon will lead MHRA after June Raine retires Lawrence Tallon has been named head of the MHRA, effective 1st April, replacing Dame June Raine who is retiring.
News Indivior changes CEO after warning sales will fall in 2025 UK-listed pharma company Indivior has appointed pharma veteran Joe Ciaffoni as its new chief executive, replacing Mark Crossley.
News Ex-CDER chief Cavazzoni rejoins Pfizer as CMO In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer.
News RFK Jr-led commission will assess 'threats' to children New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.
News ESC: MSD/Bayer's Verquvo disappoints in heart failure trial Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face